{"id":"tp-58950","type":"article-newspaper","title":"Omeros Forecasts $5 Million to $6 Million in Q4 Discontinued-Operations Income","author":"John Kim","publisher":"TOKENPOST Inc.","url":"https://www.tokenpost.com/news/business/58950","datePublished":"2026-11-17T01:08:05.000Z","dateModified":"2026-11-17T01:08:05.000Z","language":"en","abstract":"YARTEMLEA gross revenue rose 29.6% sequentially in Q3. Medicare’s revised outpatient payment rate for 340B-acquired drugs, including YARTEMLEA, takes effect Jan. 1, 2027.","section":"Business","references":[]}